Related Experiment Video
Updated: Mar 8, 2026

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
Published on: August 30, 2024
Arrhythmogenic right ventricular dysplasia/cardiomyopathy
Gabriela M Orgeron1, Jane E Crosson2
11Division of Cardiology,Bloomberg Children's Center,Johns Hopkins University,Baltimore,Maryland,United States of America.
Insights
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVC) is an inherited heart condition causing dangerous arrhythmias and sudden cardiac death risk. Diagnosis involves electrical/structural assessment and genetic testing, with management focusing on therapies and defibrillators.
Area of Science:
- Cardiology
- Genetics
- Inherited Diseases
Background:
- Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVC) is a primary inherited cardiomyopathy.
- It is characterized by ventricular arrhythmias and a significant risk of sudden cardiac death.
- Diagnosis relies on established criteria including electrical and structural cardiac assessments, alongside genetic mutation analysis.
Purpose of the Study:
- To summarize the key aspects of diagnosing and managing arrhythmogenic right ventricular dysplasia/cardiomyopathy.
- To highlight the role of genetic analysis in ARVC diagnosis.
- To emphasize the importance of therapeutic interventions and risk stratification for sudden cardiac death.
Main Methods:
- Review of diagnostic criteria for ARVC.
- Analysis of current pharmacological therapies.
- Consideration of implantable defibrillator therapy for risk prevention.
- Evaluation of environmental factors, particularly exercise, in disease progression.
Main Results:
- ARVC diagnosis integrates clinical, electrical, and structural findings with genetic data.
- Management strategies include pharmacotherapy and device-based prevention of sudden cardiac death.
- Exercise is a critical environmental factor influencing ARVC development and progression.
Conclusions:
- Accurate diagnosis of ARVC requires a multi-faceted approach combining clinical evaluation and genetic testing.
- Effective management of ARVC patients involves tailored medical treatments and consideration of implantable defibrillators.
- Understanding the impact of environmental factors like exercise is crucial for managing ARVC progression and patient outcomes.
Abstract:
Arrhythmogenic right ventricular dysplasia/cardiomyopathy is an inherited cardiomyopathy characterised by ventricular arrhythmias and an increased risk of sudden cardiac death. Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnosis is based on criteria that take into account electrical and structural cardiac abnormalities, as well as mutation analysis. Appropriate pharmacological therapy and the prevention of sudden death with implantable defibrillators are important in the management of these patients. Exercise is considered an important environmental factor for the development and progression of the disease.
More Related Videos
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Rheumatic Heart Disease I: Introduction

